{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:00:34Z","timestamp":1793145634797,"version":"4.5.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2012,6,26]],"date-time":"2012-06-26T00:00:00Z","timestamp":1340668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0001688","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T14:53:38Z","timestamp":1340808818000},"page":"e1688","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Monitoring Toxicity Associated with Parenteral Sodium Stibogluconate in the Day-Case Management of Returned Travellers with New World Cutaneous Leishmaniasi"],"prefix":"10.1371","volume":"6","author":[{"given":"Emily S.","family":"Wise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret S.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana N.","family":"Lockwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,6,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives.","volume":"27","author":"P Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis.","volume":"7","author":"R Reithinger","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0035-9203(93)90398-A","article-title":"Fifteen years if cutaenous and mucocutaneous leishmaniais in Bolivia: a retrospective study.","volume":"87","author":"C David","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/qjmed\/hch127","article-title":"New World mucosal and cutanous leishmaniasis: an emerging health problem among British travellers.","volume":"97","author":"SD Lawn","year":"2004","journal-title":"Q J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jramc-151-02-03","article-title":"Clinical Guidelines for the Management of cutaneous leishmaniasis in British military personnel.","volume":"151","author":"M Bailey","year":"2005","journal-title":"J R Army Med Corps"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(87)93053-4","article-title":"Safety and efficacy of high-dose sodium stibogluconate therapy of Amercian cutaneous leishmaniasis.","volume":"2","author":"WR Ballou","year":"1987","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9343(90)90292-L","article-title":"Efficacy of ketoconazole against Lesihmania braziliensis panamensis cutaneous leishmaniasis.","volume":"89","author":"RE Saenz","year":"1990","journal-title":"Am J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4269\/ajtmh.1990.42.43","article-title":"Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala.","volume":"42","author":"TR Navin","year":"1990","journal-title":"Am J Trop Med Hyg"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1086\/341406","article-title":"A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutenous leishmaniasis in United States military personnel.","volume":"35","author":"G Wortmann","year":"2002","journal-title":"CID"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1992.46.296","article-title":"Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies.","volume":"46","author":"BL Herwaldt","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"ref11"},{"key":"ref12","article-title":"Centers for Disease Control and Prevention website."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World.","volume":"118","author":"LF Oliveira","year":"2011","journal-title":"Acta Trop"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1086\/515027","article-title":"Safety and efficacy of intravenous sodium stibogluconate in treatment of leishmaniasis: recent U.S. military experience.","volume":"27","author":"NE Aronson","year":"1998","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0035-9203(93)90298-5","article-title":"Thrombocytopaenia complicating sodium stibogluconate therapy for cutaneous leishmaniasis.","volume":"87","author":"NC Hepburn","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1086\/514689","article-title":"Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutenous leishmaniasis.","volume":"27","author":"GW Wortmann","year":"1998","journal-title":"Clin Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/qjmed\/92.11.659","article-title":"Out-patient parenteral antimicrobial therapy-a viable option for the management of cutaneous leishmaniasis.","volume":"92","author":"RA Seaton","year":"1999","journal-title":"Q J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4269\/ajtmh.2006.74.591","article-title":"Varicella zoster virus meningitis complicating sodium stibogluconate treatment for cutaneous leishmaniasis.","volume":"74","author":"JD Hatzell","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.trstmh.2005.03.012","article-title":"Electrocardiographic and biochemical adverse effects of sodium stibogluconate during treatment of cutaneous and mucosal leishmaniasis among returned travellers.","volume":"100","author":"SD Lawn","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0140-6736(93)92327-P","article-title":"Hepatotoxicity of sodium stibogluconate in leishmaniasis.","volume":"342","author":"NC Hepburn","year":"1993","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/clinids\/18.1.83","article-title":"Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis.","volume":"18","author":"RA Gasser Jr","year":"1994","journal-title":"Clin Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/clinids\/21.3.710","article-title":"Pancreatic necrosis following treatment of leishmaniasis with sodium stibogluconate.","volume":"21","author":"MO McBride","year":"1995","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2165\/00003495-199856060-00005","article-title":"Practical guide for the treatment of leishmaniasis.","volume":"56","author":"RN Davidson","year":"1998","journal-title":"Drugs"},{"key":"ref24","first-page":"465","article-title":"Cardiac effects of sodium stibogluconate: myocardial, electrophysiological and biochemical studies.","volume":"87","author":"NC Hepburn","year":"1994","journal-title":"Q J Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.1985.34.702","article-title":"Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate).","volume":"34","author":"JD Chulay","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0035-9203(85)90199-3","article-title":"Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine.","volume":"79","author":"AD Bryceson","year":"1985","journal-title":"Trans R Soc Trop Med and Hyg"},{"key":"ref27","article-title":"Glucocorticoids as a novel approach to the treatment of disabling side effects of sodium stibogluconate.","author":"JM Brostoff","year":"2011","journal-title":"J Clin Pharm Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4269\/ajtmh.2011.10-0155","article-title":"Randomised controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis caused by <italic>Leishmania (viannia) guyanensis<\/italic> in Manaus, Brazil.","volume":"84","author":"A Chrusciak-Talhari","year":"2011","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"e912","DOI":"10.1371\/journal.pntd.0000912","article-title":"Miltefosine in the treatment of cutaneous leishmaniasis caused by <italic>Leishmania braziliensis<\/italic> in Brazil: a randomised and controlled trial.","volume":"4","author":"PR Machado","year":"2010","journal-title":"PLoS Negl Trop Dis"}],"updated-by":[{"DOI":"10.1371\/annotation\/15ab4f39-31e7-40bc-9b15-6e90a612b49a","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2012,9,26]],"date-time":"2012-09-26T00:00:00Z","timestamp":1348617600000}}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0001688","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T17:28:58Z","timestamp":1589045338000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0001688"}},"subtitle":[],"editor":[{"given":"Edgar M.","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,6,26]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0001688","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/15ab4f39-31e7-40bc-9b15-6e90a612b49a","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,26]]}}}